Penumbra (PEN) Other Gross PP&E Adjustments (2014 - 2026)
Penumbra (PEN) reported Other Gross PP&E Adjustments of -$170.3 million for Q1 2026, up 2.88% year-over-year from -$165.5 million in Q1 2025, and down 208.62% quarter-over-quarter from $156.8 million in Q4 2025.
Penumbra (PEN) Other Gross PP&E Adjustments (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Other Gross PP&E Adjustments data on file, last reported at -$170.3 million in Q1 2026.
- Other Gross PP&E Adjustments for Q1 2026 came in at -$170.3 million, up 2.88% year-over-year; the trailing twelve-month figure through Mar 2026 was -$170.3 million (up 2.88% YoY), and the FY2025 annual result was $156.8 million, up 412.92% from the prior year.
- Other Gross PP&E Adjustments retreated to -$170.3 million in Q1 2026 per PEN's latest filing, from $156.8 million in the prior quarter.
- Over five years, Other Gross PP&E Adjustments peaked at $156.8 million in Q4 2025 and troughed at -$187.5 million in Q2 2023.
- A 5-year average of -$71.8 million and a median of -$50.1 million in 2024 frame the typical range for Other Gross PP&E Adjustments.
- On a YoY basis, Other Gross PP&E Adjustments climbed as much as 428.3% in 2024 and fell as far as 470.62% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$92.1 million in 2022, then increased by 28.84% to -$65.5 million in 2023, then increased by 23.54% to -$50.1 million in 2024, then jumped by 412.92% to $156.8 million in 2025, then plunged by 208.62% to -$170.3 million in 2026.
- Business Quant data shows PEN's Other Gross PP&E Adjustments at -$170.3 million in Q1 2026, $156.8 million in Q4 2025, and -$170.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 23.14 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -405.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -547.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -99.30 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 5.30 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 2.39 Bn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 991.00 Mn |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | -170.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -170.27 Mn |
| Mar 31, 2026 | -170.27 Mn |
| Dec 31, 2025 | 156.76 Mn |
| Dec 31, 2025 | 156.76 Mn |
| Sep 30, 2025 | -170.72 Mn |
| Sep 30, 2025 | -170.72 Mn |
| Jun 30, 2025 | -174.06 Mn |
| Jun 30, 2025 | -174.06 Mn |
| Mar 31, 2025 | -175.33 Mn |
| Mar 31, 2025 | -175.33 Mn |
| Dec 31, 2024 | -50.10 Mn |
| Dec 31, 2024 | -50.10 Mn |
| Sep 30, 2024 | 102.97 Mn |
| Sep 30, 2024 | 102.97 Mn |
| Jun 30, 2024 | -40.43 Mn |
| Jun 30, 2024 | -40.43 Mn |
| Mar 31, 2024 | -185.85 Mn |
| Mar 31, 2024 | -185.85 Mn |
| Dec 31, 2023 | -65.52 Mn |
| Dec 31, 2023 | -65.52 Mn |